Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2026 01:31 ET | Source: Faraday Future

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: On January 7, 2026, Faraday Future will Host a Stockholders’ Day, an Event Dedicated to Transparency, Execution Updates, and Long-Term Value Creation

FF and AIxC have signed a non-binding term sheet that contemplates a purchase of $10 million in FFAI common stock. If completed, AIxC notes that it intends to use the Common Stock to explore digital...
January 05, 2026 01:16 ET | Source: Burning Rock Biotech Limited

Burning Rock Announces Founder’s Purchase of Its ADSs

Burning Rock Announces Founder’s Purchase of Its ADSs
January 05, 2026 01:00 ET | Source: argenx SE

argenx Announces Leadership Transition Marking Next Evolution of Growth

Tim Van Hauwermeiren to transition from CEO to Non-Executive Director and Chairman of Board of Directors and Karen Massey to transition from COO to CEO and Executive Director January 5, 2026 7:00...
January 05, 2026 01:00 ET | Source: SEALSQ

SEALSQ C-Suite Visits India to Advance Post-Quantum Semiconductor Personalization Center, Quantum Investments, and Sovereign Space Capabilities

Geneva, Switzerland, Jan. 05, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum...
January 04, 2026 19:00 ET | Source: HUTCHMED (China) Limited

HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the Phase III...
January 04, 2026 16:00 ET | Source: Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia

SAN DIEGO, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on Monday, January 5, 2026 at...
January 02, 2026 17:49 ET | Source: Fidelity Deposit & Discount Bank

Fidelity Bank Welcomes James Clemente, CPA, MT and Rocco A. DelVecchio to Board of Directors

DUNMORE, Pa., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Brian J. Cali, Chairman of the Board of Fidelity Bank, is pleased to announce the appointment of James Clemente, CPA, MT and Rocco A. DelVecchio to...
January 02, 2026 17:20 ET | Source: Riot Platforms, Inc.

Riot Platforms Announces Chief Financial Officer Transition

CASTLE ROCK, Colo., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or the “Company”) today announced the appointment of Jason Chung as Chief Financial Officer of the...
January 02, 2026 17:00 ET | Source: MKDWELL Tech Inc.

MKDW repurchased approximately $7 million worth of its outstanding ordinary shares.

Hsinchu, Taiwan, Jan. 02, 2026 (GLOBE NEWSWIRE) -- MKDWELL Tech Inc. (NASDAQ: MKDW) (“MKDWELL” or the “Company”), an automotive electronics manufacturer, today announced that it has entered into...
January 02, 2026 17:00 ET | Source: Westport Fuel Systems Inc.

Westport Announces Board of Directors Update

VANCOUVER, British Columbia, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Westport Fuel Systems Inc. (“Westport") (TSX:WPRT / Nasdaq: WPRT), a supplier of alternative fuel systems and components for the global...